Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01765179 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Trial of Testosterone Undecanoate
A Phase 3 study of Male Hypogonadism, sponsored by Clarus Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 144
- Enrollment target
- 20
- Study locations
NCT01765179 is a Phase 3 study of Male Hypogonadism that has completed, run by Clarus Therapeutics. The registered enrollment target is 144 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT01765179, a Phase 3 study of Male Hypogonadism, has completed, sponsored by Clarus Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 144 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to determine if oral testosterone undecanoate is effective and safe in the treatment of low testosterone in men.
Conditions Studied
Interventions
- DRUG Oral testosterone undecanoate
Study Locations (20)
California
- SC Clinical Research, Inc. - Garden Grove
- South ORange County Endocrinology - Laguna Hill
- Tower Urology, Tower Research Institute - Los Angeles
- San Diego Sexual Medicine - San Diego
- LABiomedical Research Institute at Harbor-UCLA Medical Center - Torrance
Arizona
- Precision Trials/Valley Urologic Associates - Glendale
- Premier Clinical Research Center - Phoenix
- Precision Trials/Valley Urologic Associates - Phoenix
- Quality of LIfe Medical and Research Center - Tucson
Florida
- South Florida Medical Research - Aventura
- PAB Clinical Research - Brandon
- Innovative Research of West Florida - Clearwater
- Jacksonville Impotence Treatment Center - Jacksonville
Alabama
- Alabama Clinical Therapeutics, LLC - Birmingham
- Alabama Internal Medicine, PC - Birmingham
- Medical Affliated Research Center, Inc. - Huntsville
Connecticut
- Conneticut Clinical Research Center - Middlebury
New York
- University Urology Associates - New York
Oregon
- Sunstone Medical Research - Medford
Pennsylvania
- Unrologic Consultants of SE Pennsylvania - Bala-Cynwyd
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01765179
The ClinicalTrials.gov registry entry for NCT01765179 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clarus Therapeutics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Male Hypogonadism appearing as the primary indexed condition, and to 1 intervention - of which Oral testosterone undecanoate is the first listed.
NCT01765179 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT01765179 about?
NCT01765179 is a clinical study titled "Safety and Efficacy Trial of Testosterone Undecanoate". The purpose of the study is to determine if oral testosterone undecanoate is effective and safe in the treatment of low testosterone in men.
What is the current status of trial NCT01765179?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 144 participants. The study started on 2013-01. Estimated completion is 2013-07.
What conditions does trial NCT01765179 study?
This clinical trial studies the following conditions: Male Hypogonadism.
What interventions are being tested in trial NCT01765179?
The interventions under investigation include: Oral testosterone undecanoate (DRUG).
Who is sponsoring clinical trial NCT01765179?
This trial is sponsored by Clarus Therapeutics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01765179 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Male Hypogonadism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.